Combined CDK4/6 and PI3Kα Inhibition Is Synergistic and Immunogenic in Triple-Negative Breast Cancer

New treatments for triple-negative breast cancer (TNBC) are urgently needed. Despite there being little evidence of clinical activity as single-agent therapies, we show that dual blockade of PI3Kα and CDK4/6 is synergistically effective against multiple -wild-type TNBC models. Combined PI3Kα and CDK...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 2017-11, Vol.77 (22), p.6340-6352
Hauptverfasser: Teo, Zhi Ling, Versaci, Stephanie, Dushyanthen, Sathana, Caramia, Franco, Savas, Peter, Mintoff, Chris P, Zethoven, Magnus, Virassamy, Balaji, Luen, Stephen J, McArthur, Grant A, Phillips, Wayne A, Darcy, Phillip K, Loi, Sherene
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!